Mitochondrial genome variants associated with amyotrophic lateral sclerosis and their haplogroup distribution

Marcelo R. S. Briones PhD, João H. Campos PhD, Renata C. Ferreira PhD, Lisa Schneper PhD, Ilda M. Santos MSc, Fernando M. Antoneli PhD, NYGC ALS Consortium , James R. Broach PhD

Introduction/Aims Amyotrophic lateral sclerosis (ALS) may be familial or sporadic, and twin studies have revealed that even sporadic forms have a significant genetic component. Variants in 55 nuclear genes have been associated with ALS and although mitochondrial dysfunction is observed in ALS, variants in mitochondrial genomes (mitogenomes) have not yet been tested for association with ALS. The aim of this study was to determine whether mitogenome variants are associated with ALS.

Methods We conducted a genome-wide association study (GWAS) in mitogenomes of 1965 ALS patients and 2547 controls.

Results We identified 51 mitogenome variants with p values <10?7, of which 13 had odds ratios (ORs) >1, in genes RNR1, ND1, CO1, CO3, ND5, ND6, and CYB, while 38 variants had OR <1 in genes RNR1, RNA2, ND1, ND2, CO2, ATP8, ATP6, CO3, ND3, ND4, ND5, ND6, and CYB. The frequencies of haplogroups H, U, and L, the most frequent in our ALS data set, were the same in different onset sites (bulbar, limb, spinal, and axial). Also, intra-haplogroup GWAS revealed unique ALS-associated variants in haplogroups L and U.

Discussion Our study shows that mitogenome single nucleotide variants (SNVs) are associated with ALS and suggests that these SNVs could be included in routine genetic testing for ALS and that mitochondrial replacement therapy has the potential to serve as a basis for ALS treatment.

---